Gates Scholar’s contribution to diabetes research

  • June 28, 2010

A Gates Scholar is a joint first author of a new paper on the effects of diabetes, published in The Lancet.

The article, published in this week’s issue of The Lancet, shows that diabetes approximately doubles the risk of a wide range of blood vessel diseases, including heart attacks and different types of stroke.

The research is based on an analyisis of 700,000 people, each of whom was monitored for about a decade in 102 surveys conducted in 25 countries. The analysis was made by an international consortium led by Cambridge’s Dr Nadeem Sarwar and Professor John Danesh in the Cardiovascular Epidemiology Unit.

Rao Kondapally Seshasai is a joint first author of this research, which will also be presented at the American Diabetes Association’s 70th Scientific Sessions in Orlando, Florida.

Rao features also this week, alongside Gates Scholar Sebhat Erqou, in research published in the Archives of Internal Medicine on the use of statins. Contrary to previous reports based on more limited data, the research has found that short-term use of statins in patients without a history of heart attacks and strokes has only a borderline effect.

Latest News

Towards a dictionary of the human genome

Marie Brunet’s research focuses on the secrets still hidden in our genomes. She says that despite the fact that we live in an era where getting our genome sequenced is possible, we still don’t know the origin of two fifths of inherited diseases. That is because, as she says, the genome only currently maps the […]

Scholar recognised for research into misinformation

A Gates Cambridge Scholar has been shortlisted for a Women of the Future Award for her research into countering misinformation. Melisa Basol [2018] was shortlisted for the science category of the UK Awards which recognises “truly remarkable female scientists, forging new ground in research and scientific achievement”. There are 11 other categories and three special […]

Scholars join forces on anti-cancer drug

Two Gates Cambridge Scholars have joined forces to work on a drug candidate that has the potential to replace one of the most widely used cancer drugs around the world. Dr Anand Jeyasekharan [2004], who did his PhD in Oncology, and Dr Chandler Robinson [2009] who did an MBA at Cambridge, will collaborate on a […]

Making the experiences of imprisoned women activists visible

Growing up in a small town in Bengal, Jigisha Bhattacharya [2022] developed a particular sensitivity to marginalised groups and conflicts between different communities and identities from an early age.  It is this interest and her experience of political protests at university, combined with a longstanding curiosity about the links between politics and the arts, that […]